
Pfizer Inc. has filed a lawsuit against Metsera Inc. and Danish drugmaker Novo Nordisk A/S, aiming to block Novo's bid for the obesity treatment startup.
The legal move comes as a fast-developing battle over Metsera, which is developing potential oral and injectable treatments for obesity and diabetes.